Positive CHMP opinion for Buvidal (buprenorphine) 160mg monthly dose for treatment of opioid dependence

The new 160mg monthly dose of Buvidal® (buprenorphine) prolonged release injection will mean multiple weekly and monthly dosing options can be offered for the treatment opioid dependence in adults and adolescents from 16 years of age.

Biospace Inc.